药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dacarbazine
Temefos
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Temefos.
Dacarbazine
CUDC-907
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with CUDC-907.
Dacarbazine
Anisodamine
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Anisodamine.
Dacarbazine
Bilastine
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Bilastine.
Dacarbazine
Phosmet
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Phosmet.
Dacarbazine
Fenthion
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Fenthion.
Dacarbazine
Famphur
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Famphur.
Dacarbazine
Dichlorvos
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Dichlorvos.
Dacarbazine
Coumaphos
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Coumaphos.
Dacarbazine
Acrivastine
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Acrivastine.
Dacarbazine
Olodaterol
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Olodaterol.
Dacarbazine
Chlorcyclizine
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Chlorcyclizine.
Dacarbazine
Bupranolol
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Bupranolol.
Dacarbazine
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Geranylgeranyl diphosphate.
Dacarbazine
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Farnesyl diphosphate.
Dacarbazine
Triptorelin
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Triptorelin.
Dacarbazine
Histrelin
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Histrelin.
Dacarbazine
Buserelin
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Buserelin.
Dacarbazine
Degarelix
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Degarelix.
Dacarbazine
Mepyramine
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Mepyramine.